13 Best Stocks to Invest In on Robinhood for Beginners

10. Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Number of Hedge Fund Holders: 44  

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is among the best Robinhood stocks. 

TheFly reported on March 17 that JPMorgan increased its price target for EWTX from $34 to $45 while keeping an Overweight rating on the stock. The firm also added EWTX to its Analyst Focus List as a growth opportunity, highlighting optimism around upcoming pipeline catalysts, especially renewed attention on EDG-7500. Anticipation builds for the full 12-week data expected in Q2, which could significantly influence the fundamental outlook for EDG-7500. JPMorgan views the overall setup for EWTX in 2026 as increasingly favorable, reflecting confidence in the company’s potential and the opportunities presented by its pipeline developments.

Separately, earlier on March 10, Edgewise Therapeutics, Inc. (NASDAQ:EWTX) shared long-term results from its MESA open-label extension study evaluating sevasemten in Becker muscular dystrophy, a condition with no approved treatments. The findings indicate that patients on sevasemten maintained stable functional abilities over 3.5 years, contrasting with the expected decline observed in the Becker natural history.

After prior 12-month ARCH and CANYON assessments, continued follow-ups confirmed sustained stabilization and a favorable safety profile with extended exposure. The company plans to release top-line data from the placebo-controlled GRAND CANYON pivotal cohort in the fourth quarter, which could support sevasemten’s progression toward regulatory approval for this underserved patient population.

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is a clinical‑stage biopharmaceutical company developing novel precision therapies for serious muscle disorders, including Duchenne and Becker muscular dystrophies and cardiac conditions, with an advanced pipeline of small‑molecule drug candidates targeting muscle biology.